Authors of a study published in JAMA Network Open suggest that clinical treatment guidelines should be updated to include the initiation of biosimilars immediately after the...
Large language models (LLMs) featuring generative artificial intelligence (AI) can rapidly and accurately screen patients with heart failure (HF) for eligibility in clinical trials, which could...
According to new clinical trial results, an experimental 1-time gene editing cell therapy, renizgamglogene autogedtemcel (reni-cel, formerly called EDIT-301), was well-tolerated in patients with sickle cell...
The recent approval of Moderna’s respiratory syncytial virus (RSV) vaccine mRNA-1345 (mRESVIA) could encourage the use of mRNA technology across different landscapes.1 The FDA approved mRNA-1345...
Daniel J. Drucker, MD, from Mt. Sinai Hospital, said, for glucagon-like peptide-1 (GLP-1) medications, the brain is responsible for many of the common gastrointestinal adverse events...
At the ADA 84th Scientific Sessions, new data from the SELECT (NCT03574597) trial shows semaglutide’s effect on glycemia, inflammation, and heart failure, demonstrating that the drug...
Although weight loss is a common consideration for patients initiating treatment with glucagon-like peptide (GLP)-1 receptor agonists, managing these treatments involves many considerations, including glycemic control...
Alzheimer disease (AD) is an age-related neurodegenerative condition that is multifaceted, intricate, irreversible and advances over time. In individuals older than 60 years, the incidence of...
A third person has tested positive for avian influenza (flu, HPAI) H5N1 virus in the United States. The CDC assures that the risk to the general...
Serotypes included in V116 (Merck), a 21-valent pneumococcal conjugate vaccine (PCV), have a higher clinical and economic burden for invasive pneumococcal disease (IPD) compared with PCV20...
Opioid use disorder (OUD) is a problematic pattern of opioid use that causes significant impairment or distress.1 In 2022, an estimated 6.1 million Americans had a...